Insider Transactions in Q3 2024 at Amphastar Pharmaceuticals, Inc. (AMPH)
Insider Transaction List (Q3 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 13
2024
|
Rong Zhou SENIOR EVP, PRODUCTION CENTER |
SELL
Open market or private sale
|
Direct |
3,000
-2.47%
|
$144,000
$48.26 P/Share
|
Sep 13
2024
|
Rong Zhou SENIOR EVP, PRODUCTION CENTER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+2.41%
|
$42,000
$14.95 P/Share
|
Sep 13
2024
|
Jack Y. Zhang CEO & CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+3.66%
|
$1,400,000
$14.69 P/Share
|
Sep 05
2024
|
Floyd F. Petersen |
SELL
Open market or private sale
|
Direct |
3,000
-3.83%
|
$138,000
$46.47 P/Share
|
Aug 26
2024
|
Rong Zhou SENIOR EVP, PRODUCTION CENTER |
SELL
Open market or private sale
|
Direct |
4,000
-3.27%
|
$192,000
$48.35 P/Share
|
Aug 26
2024
|
Rong Zhou SENIOR EVP, PRODUCTION CENTER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+3.16%
|
$56,000
$14.95 P/Share
|
Aug 12
2024
|
Richard K Prins |
SELL
Open market or private sale
|
Direct |
17,101
-33.48%
|
$735,343
$43.07 P/Share
|
Aug 12
2024
|
Richard K Prins |
BUY
Exercise of conversion of derivative security
|
Direct |
17,101
+11.24%
|
$324,919
$19.88 P/Share
|
Jul 31
2024
|
William J Peters CFO, EVP & TREASURER |
SELL
Open market or private sale
|
Direct |
10,282
-9.85%
|
$452,408
$44.23 P/Share
|
Jul 31
2024
|
William J Peters CFO, EVP & TREASURER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,282
+8.97%
|
$205,640
$20.23 P/Share
|